BPG is committed to discovery and dissemination of knowledge
Citation
Sherman KE, Kang M, Sterling R, Umbleja T, Marks K, Kiser JJ, Alston-Smith B, Greaves W, Butt AA, the ACTG 5294 BIRTH Study Team. Phase 3 trial of first generation protease inhibitor therapy for hepatitis C virus/human immunodeficiency virus coinfection. World J Hepatol 2017; 9(4): 217-223 [PMID: 28217259 DOI: 10.4254/wjh.v9.i4.217]
Please LOGIN to submit a new comment.